Anti-counterfeit Pharmaceutical Packaging Market to Witness a Pronounce Growth by 2026

Anti-counterfeit packaging is primarily used to prevent brand imitation, by enabling brand protection and ease for customers to distinguish between original and counterfeit products. Product imitations of clothing, electronics, pharmaceuticals, and other consumer goods are of poorer quality and do not meet stipulated safety standards. The imitations are sold in violation of law, incurs revenue loss on the company, and affects brand image. According to the Organization for Economic Co-operation and Development (OECD), counterfeiting costs the global economy US$ 250 billion per year. Around 10% of pharmaceuticals around the world are counterfeit, according to the WHO. Counterfeiting can take place anywhere across the supply chain and is difficult to regulate.

The anti-counterfeiting pharmaceutical packaging market is mainly driven by the consequences associated with the use of counterfeit product. Ingestion of counterfeit drugs may lead to serious health issues or death. Moreover, anti-counterfeit packaging are guarantors of product quality, in turn, driving sales of the product. Significant costs associated with adoption of security measures and lack of awareness among consumers about product authenticity are major factors restraining growth of the market.

Request for Sample Copy of this Report :
https://www.coherentmarketinsights.com/insight/request-sample/865

Track and Trace features allows determination of location of products. Overt features are visible to the naked eye and are tactile, while covert features are only visible to trained personnel using specialized tools. Forensic features can only be observed in laboratory settings, whereas tamper evidence packaging is designed to reveal any interference with product.

Pharmaceutical and Food & Beverages are the largest end-use industries. Companies are involved in increasing security measures due to increased tampering and adulteration of food and medicines. This in turn, drives the anti-counterfeit pharmaceutical packaging market.

Anti-counterfeit Pharmaceutical Packaging Market Outlook

Europe and North America are the largest markets for anti-counterfeit pharmaceutical packaging. The countries in these regions have stringent regulations regarding counterfeit sales and manufacture. Particularly, the increase in counterfeit online products has plagued these regions. Third party sellers on online platforms can easily evade detection and source products from other countries. This makes counterfeiting measures vital in these regions as they are the largest consumer markets in the world.

Asia-Pacific is the largest market for counterfeit pharmaceuticals. In September 2016, the World Customs Organization (WCO) seized 113 million counterfeit tablets bound for Africa, out of which 97% were manufactured in India and China. Growing awareness among manufacturers and consumers regarding counterfeiting is expected to boost growth of the market in the region.

In Latin America, Brazil, Mexico, and Argentina are among the largest producers of generic drugs. Copying of branded drugs coupled with lenient regulations regarding brand protection are major issues. This trend is expected to reverse and the region is expected to experience significant growth, as countries introduce new counterfeit legislation.

In the Middle East, GCC countries have strict border regulations, which has ensured minimal counterfeit product penetration. Moreover, stringent commercial legislation in countries such as Saudi Arabia and UAE has driven growth of the market in the region.
Africa is a major victim of counterfeit drugs. Poverty stricken countries in this region are reliant on medical aid from other regions. Lack of awareness has resulted in growth of counterfeit market. Increasing economic growth in the region and growing awareness among the populace regarding ill effects of counterfeiting products, is projected to boost growth of the market in this region.

In March 2014, SICPA Holdings S.A acquired Cabot Security Materials Inc. (CSMI). SICPA is a major worldwide provider of security inks and solution for bank notes, passports, transport tickets, and plastic cards. While, CSMI is a major covert taggants for anti-counterfeiting industry. By this acquisition CSMI has generated US$7 million revenue in 2013.

Key player in Anti-counterfeit Pharmaceutical Packaging Market

The major players in the anti-counterfeit pharmaceutical packaging market include SICPA Holding SA, Applied DNA Sciences Inc., SAVI Technology, Inc., Authentix Inc., Avery Dennison Corporation, CCL Industries Inc., 3M Compny, E.I. du Pont de Nemours and Company, and Zebra Technologies Corporation.

For More Information :
https://www.coherentmarketinsights.com/ongoing-insight/anti-counterfeit-pharmaceutical-packaging-market-865

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services and competitive analysis through various recommendations related to emerging market trends, technologies and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.